On March 22, 2021, Federal Magistrate Judge Vera M. Scanlon of the Eastern District of New York denied a motion brought by Microgenics Corporation and Thermo Fisher Scientific, Inc. to dismiss a proposed class-action lawsuit filed by ECBAWM and Prisoners’ Legal Services of New York on behalf of state prisoners who were severely punished based solely on the unreliable drug testing services supplied by Defendants. The Court’s decision means that ECBAWM and PLS-NY will continue to press forward with their efforts to hold Defendants accountable for the severe harms hundreds of people suffered, including being wrongfully placed in solitary confinement, being removed from family reunification programs, and even being held in prison beyond their sentences.

ECBAWM’s Matthew D. Brinckerhoff and Ananda Burra represent the plaintiffs.